Cargando…

Risk Factors for Metabolic Syndrome Independently Predict Arterial Stiffness and Endothelial Dysfunction in Patients With Chronic Kidney Disease and Minimal Comorbidity

OBJECTIVE: Metabolic syndrome (MS) is common in patients with chronic kidney disease (CKD), but its contribution to arterial stiffness and endothelial dysfunction in CKD is not well defined. We hypothesized that risk factors for MS would independently predict arterial stiffness and endothelial dysfu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lilitkarntakul, Pajaree, Dhaun, Neeraj, Melville, Vanessa, Kerr, Debbie, Webb, David J., Goddard, Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402254/ https://www.ncbi.nlm.nih.gov/pubmed/22648437 http://dx.doi.org/10.2337/dc11-2345

Ejemplares similares

Arterial stiffness & Sri Lankan chronic kidney disease of unknown origin
por: Gifford, Fiona, et al.
Publicado: (2016)

Plasma Pro‐Endothelin‐1 Peptide Concentrations Rise in Chronic Kidney Disease and Following Selective Endothelin A Receptor Antagonism
por: Dhaun, Neeraj, et al.
Publicado: (2015)

Chorioretinal thinning in chronic kidney disease links to inflammation and endothelial dysfunction
por: Balmforth, Craig, et al.
Publicado: (2016)

First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis
por: Hunter, Robert W., et al.
Publicado: (2017)

Prospective management of end-stage renal failure within a conservative care programme
por: Dhaun, Neeraj, et al.
Publicado: (2013)

Antineutrophil cytoplasm antibody positivity, kidney impairment, and cholesterol embolization
por: Farrah, Tariq E., et al.
Publicado: (2021)

The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons
por: Farrah, Tariq E., et al.
Publicado: (2020)

Extracellular RNA in kidney disease: moving slowly but surely from bench to bedside
por: Hunter, Robert W., et al.
Publicado: (2020)

Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2019)

Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function
por: Nyimanu, Duuamene, et al.
Publicado: (2022)

Correction to: Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2020)

Progression of endothelial dysfunction, atherosclerosis, and arterial stiffness in stable kidney transplant patients: a pilot study
por: Junarta, Joey, et al.
Publicado: (2020)

Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease
por: Scullion, Kathleen M., et al.
Publicado: (2020)

Investigation of endothelial dysfunction and arterial stiffness in multisystem inflammatory syndrome in children
por: Çiftel, Murat, et al.
Publicado: (2021)

Arterial stiffness but not endothelial dysfunction is associated with multidrug antihypertensive therapy and nondipper blood pressure pattern in kidney transplant recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2018)

Endothelial Dysfunction in Kidney Transplantation
por: Cardinal, Héloïse, et al.
Publicado: (2018)

HIV and race are independently associated with endothelial dysfunction
por: Mouchati, Christian, et al.
Publicado: (2023)

Arterial Stiffness Can Be Modulated by Pressure‐Independent Mechanisms in Hypertension
por: Faconti, Luca, et al.
Publicado: (2019)

Endothelial dysfunction and arterial stiffness in pre-eclampsia demonstrated by the EndoPAT method
por: Meeme, A, et al.
Publicado: (2017)

Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
por: Tzoumas, Nikolaos, et al.
Publicado: (2020)

The Role of Tissue Renin-Angiotensin-Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness
por: Aroor, Annayya R., et al.
Publicado: (2013)

The therapeutic potential of apelin in kidney disease
por: Chapman, Fiona A., et al.
Publicado: (2021)

The Correlation of Arterial Stiffness Parameters with Aging and Comorbidity Burden
por: Fantin, Francesco, et al.
Publicado: (2022)

Comment on: A novel model to assess disease activity in Takayasu arteritis based on (18)F-FDG PET/CT: a Chinese cohort study
por: Pugh, Dan, et al.
Publicado: (2021)

Subendothelial stiffness alters endothelial cell traction force generation while exerting a minimal effect on the transcriptome
por: Bastounis, Effie E., et al.
Publicado: (2019)

Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review
por: Naidoo, Nitalia, et al.
Publicado: (2021)

Endothelial dysfunction: The possible link between cardiovascular comorbidities and phenomenon of inflammaging from COPD
por: Tudorache, Emanuela, et al.
Publicado: (2022)

A Review on COVID-19: Primary Receptor, Endothelial Dysfunction, Related Comorbidities, and Therapeutics
por: Assareh, Elham, et al.
Publicado: (2023)

HIV is an independent predictor of aortic stiffness
por: Rider, Oliver J, et al.
Publicado: (2014)

Association Between Arterial Stiffness and Measures of Autonomic Dysfunction in People With Chronic Kidney Disease
por: Davies, Rachelle, et al.
Publicado: (2023)

Glycated Albumin is Independently Associated With Arterial Stiffness in Non-Diabetic Chronic Kidney Disease Patients
por: Choi, Hoon Young, et al.
Publicado: (2016)

TWEAK: a novel biomarker for lupus nephritis?
por: Dhaun, Neeraj, et al.
Publicado: (2009)

Pulse-wave velocity is associated with cognitive impairment in haemodialysis patients
por: Miller-Hodges, Eve, et al.
Publicado: (2017)

Endothelial Dysfunction and Arterial Stiffness in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Wu, Hao, et al.
Publicado: (2022)

Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes
por: Jojima, Teruo, et al.
Publicado: (2022)

Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure
por: Cassano, Velia, et al.
Publicado: (2022)

Kidney Function and Aortic Stiffness, Pulsatility, and Endothelial Function in African Americans: The Jackson Heart Study
por: Nagarajarao, Harsha S., et al.
Publicado: (2021)

Chronic kidney disease with comorbid cardiac dysfunction exacerbates cardiac and renal damage
por: Liu, Shan, et al.
Publicado: (2017)

Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction
por: Liew, Hui, et al.
Publicado: (2021)

Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease
por: Farrah, Tariq E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_anomlsormb9unheptpgm6ml7c5